summerland serums' multi-brown snake antivenom
summerland serums pty ltd - brown snake antivenom; phenol - parenteral liquid/solution/suspension - brown snake antivenom antivenom-snake active 1650.0 units; phenol phenol other 2.2 mg/ml - immunotherapy - animal - antivenom - tiger snake bite | brown snake bite - pseudonaja spp. | brown snake bite - pseudonaja textilis | dugite | eastern brown snake | gwardar | ringed brown snake | western brown snake
summerland serums' tiger/multi-brown snake antivenom
summerland serums pty ltd - brown snake antivenom; tiger snake antivenom; phenol - parenteral liquid/solution/suspension - brown snake antivenom antivenom-snake active 4050.0 units; tiger snake antivenom antivenom-snake active 4050.0 units; phenol phenol other 2.2 mg/ml - immunotherapy - animal - antivenom - tiger snake bite | brown snake bite - pseudonaja spp. | brown snake bite - pseudonaja textilis | dugite | eastern brown snake | gwardar | ringed brown snake | western brown snake
brown snake antivenom (equine) 1000u injection vial
seqirus pty ltd - brown snake antivenom, quantity: 1000 u - injection, concentrated - excipient ingredients: phenol; sodium chloride; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a snake of the genus pseudonaja. this genus includes the eastern brown snake, the dugite and the gwardar (western brown snake).
a.v.s.l multi brown snake antivenom
ausvetlab pty ltd - brown snake antivenom; phenol - parenteral liquid/solution/suspension - brown snake antivenom antivenom-snake active 0.0 p; phenol phenol other 0.0022 ml/ml - immunotherapy - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - antiserum | brown snake bite - pseudonaja spp. | dugite | eastern brown snake | gwardar | ringed brown snake | western brown snake
brown snake antivenom
zoetis australia pty ltd - brown snake antivenom | equine plasma protein (refined by enzyme treatment) - immunotherapy - cat | dog | horse | bitch | castrate | cat - queen | cat - tom | colt | donkey | endurance horse | filly | foal | gelding | high - brown snake bite - pseudonaja textilis
brown snake antivenom
brown snake antivenom -
brown snake antivenom 2000 units
padula serums pty. ltd. - equine immunoglobulin protein - brown snake antivenom; phenol - misc. vaccines or anti sera - equine immunoglobulin protein - brown snake antivenom antivenom-snake active 2000.0 units; phenol phenol other 2.2 mg/ml - immunotherapy
tiger - brown snake combined antivenom
zoetis australia pty ltd - brown snake antivenom | tiger snake antivenom - immunotherapy - cat | dog | horse | bitch | castrate | cat - queen | cat - tom | colt | donkey | endurance horse | filly | foal | gelding | high - vaccines and antisera | brown snake bite | cheesy gland | enterotoxaemia | tetanus
lisinopril 2.5mg tablets
brown & burk uk ltd - lisinopril dihydrate - tablets - 2.5mg - ace inhibitor - hypertension: all grades of essential and renovascular hypertension. lisinopril tablets may be used alone or with other antihypertensives. congestive heart failure: lisinopril may be taken as an additional treatment with non-potassium-sparing diuretics and, where appropriate digoxin or digitoxin. commencement of lisinopril treatment should be under close medical supervision. severe heart failure should be treated in hospital. acute myocardial infarction: lisinopril may be used to treat haemodynamically stable patients (ie who are not in cardiogenic shock and who have a systolic blood pressure greater than 100 mmhg). lisinopril can be given within 24 hours of acute myocardial infarction to prevent left ventricular dysfunction, heart failure, and to increase survival prospects. patients should also receive the standard recommended treatments for this condition, ie aspirin, a beta-blocker and thrombolytics.
lisinopril 10mg tablets
brown & burk uk ltd - lisinopril dihydrate - tablets - 10mg - ace inhibitor - hypertension: all grades of essential and renovascular hypertension. lisinopril tablets may be used alone or with other antihypertensives. congestive heart failure: lisinopril may be taken as an additional treatment with nonpotassium-sparing diuretics and, where appropriate digoxin or digitoxin. commencement of lisinopril treatment should be under close medical supervision. severe heart failure should be treated in hospital. acute myocardial infarction: lisinopril may be used to treat haemodynamically stable patients (ie who are not in cardiogenic shock and who have a systolic blood pressure greater than 100 mmhg). lisinopril can be given within 24 hours of acute myocardial infarction to prevent left ventricular dysfunction, heart failure, and to increase survival prospects. patients should also receive the standard recommended treatments for this condition, ie aspirin, a beta-blocker and thrombolytics.